In order to assess the prognostic value of DACH1 and CD44 in breast cancer, a meta-analysis enrolling a total of 19 published Gene Expression Omnibus (GEO) databases and including 3574 breast cancer patients was performed26–44. This evidence concerns the gene CD44 and breast cancer.